BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 19524226)

  • 1. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
    Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
    Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
    Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility.
    Annunziata M; Luque RM; Durán-Prado M; Baragli A; Grande C; Volante M; Gahete MD; Deltetto F; Camanni M; Ghigo E; Castaño JP; Granata R
    Hum Reprod; 2012 Jul; 27(7):2117-29. PubMed ID: 22588000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.
    Chatzistamou I; Volakaki AA; Schally AV; Kiaris H; Kittas C
    Regul Pept; 2008 Apr; 147(1-3):33-6. PubMed ID: 18255167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue.
    Lee KF; Lee YL; Chan RW; Cheong AW; Ng EH; Ho PC; Yeung WS
    Fertil Steril; 2010 Mar; 93(4):1052-60. PubMed ID: 19135668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis.
    Yang JH; Chen MJ; Wu MY; Chen YC; Yang YS; Ho HN
    Fertil Steril; 2006 Nov; 86(5):1459-65. PubMed ID: 16989825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons.
    Kyama CM; Overbergh L; Mihalyi A; Cuneo S; Chai D; Debrock S; Mwenda JM; Mathieu C; Nugent NP; D'Hooghe TM
    Fertil Steril; 2008 May; 89(5 Suppl):1306-13. PubMed ID: 18061171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
    Sharma I; Dhawan V; Mahajan N; Saha SC; Dhaliwal LK
    Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro.
    Köster F; Jin L; Shen Y; Schally AV; Cai RZ; Block NL; Hornung D; Marschner G; Rody A; Engel JB; Finas D
    Reprod Sci; 2017 Nov; 24(11):1503-1511. PubMed ID: 28205459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
    Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
    Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.
    Kyama CM; Overbergh L; Mihalyi A; Meuleman C; Mwenda JM; Mathieu C; D'Hooghe TM
    Fertil Steril; 2008 Feb; 89(2):301-10. PubMed ID: 17678915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
    Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R
    Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu.
    Li MQ; Shao J; Meng YH; Mei J; Wang Y; Li H; Zhang L; Chang KK; Wang XQ; Zhu XY; Li DJ
    Hum Reprod; 2013 Oct; 28(10):2822-31. PubMed ID: 23856325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon.
    Hohla F; Moder A; Mayrhauser U; Hauser-Kronberger C; Schally AV; Varga JL; Zarandi M; Buchholz S; Huber R; Aigner E; Ritter M; Datz C
    Int J Oncol; 2008 Jul; 33(1):137-43. PubMed ID: 18575759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.